vimarsana.com

Page 12 - சிங்கப்பூர் பரிமாற்றம் பத்திரங்கள் வர்த்தக வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lonza Group AG: Lonza Announces Construction of a New Small Molecule Manufacturing Complex in Visp

Lonza Group AG: Lonza Announces Construction of a New Small Molecule Manufacturing Complex in Visp Lonza will invest CHF 200 million to construct a new manufacturing complex The 2000 m2 complex will include a customer dedicated manufacturing line for antibody-drug conjugate payload molecules The investment is supported by a long-term collaboration and capital contribution with a major biopharmaceutical partner The new manufacturing complex is designed to accommodate future small molecule expansions Quote from Maurits Janssen, Strategic Business Development Small Molecules, Lonza: Supply is critical for our global partner in the oncology field. With this investment, we are enabling the treatment of many cancer patients. Oncology continues to be the leading indication in biopharma and a key driver for highly potent ingredients such as antibody-drug conjugates. In addition, small molecule oncology therapies require specific technologies. These challenges were specifically taken i

Singapore Exchange Consults on Proposed Listing Framework for SPACs | Latham & Watkins LLP

To embed, copy and paste the code into your website or blog: The proposal covers broad admission criteria; conditions for founding shareholders, the management team, and controlling shareholders; and business combination requirements. On 31 March, the Singapore Exchange (SGX) published a consultation paper proposing a primary listing framework for special purpose acquisition companies (SPACs) to list on the Mainboard of the Singapore Exchange Securities Trading Limited (Mainboard) (SPAC Framework). Please see full Alert below for more information. Latham & Watkins operates worldwide as a limited liability partnership organized under the laws of the State of Delaware (USA) with affiliated limited liability partnerships conducting the practice in France, Hong Kong, Italy, Singapore, and the United Kingdom and as an affiliated partnership conducting the practice in Japan. Latham & Watkins operates in South Korea as a Foreign Legal Consultant Office. Latham & Watkins works in cooper

Change - Announcement Of Cessation :: Retirement Of Independent Non-Executive Director

Yes 28/04/2021 Detailed Reason (s) for cessation Mr Mahtani Bhagwandas is retiring pursuant to Regulation 90 of the Company s Constitution. He is not seeking re-election and will retire as an Independent Director on 28 April 2021 at the conclusion of the Annual General Meeting due to his current personal commitments which includes his directorships in other companies. After having interviewed Mr Mahtani Bhagwandas and to the best of its knowledge, the Company s Sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that save as disclosed in this announcement, there are no material reasons for the cessation of Mr Mahtani Bhagwandas as the Independent Director of the Company.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.